The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess
Open accessAbstract
Significance: Glucocorticoids are widely prescribed for their anti-inflammatory properties but have Cushingoid side effects that contribute significantly to patient morbidity and mortality. Here we present data to demonstrate that the adverse side-effect profile associated with exogenous active glucocorticoid (GC) administration (including glucose intolerance, hyperinsulinemia, hypertension, hepatic steatosis, increased adiposity, and myopathy) is prevented by global deletion of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) in mice. This study not only defines a significant shift in our understanding of the physiological and molecular mechanisms underpinning the adverse side effects associated with GC use but also raises the possibility of targeting 11β-HSD1 as a novel adjunctive therapy in the treatment of Cushing syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 2×
“Indeed, this was confirmed in the adipose-specific 11β-HSD1–overexpressing mice, where twofold higher intraadipose CORT levels were recorded in comparison with WT controls (9).”
BackgroundCushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Fleseriu, M., Biller, B. M. K., Findling, J. W., Molitch, M. E., Schteingart, D. E., Gross, C., on behalf of the SEISMIC Study Investigators, The SEISMIC Study Investigators include, Auchus, R., Bailey, T., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3350 · Cited by 479
Schäcke, H., Schottelius, A., Döcke, W.-D., Strehlke, P., Jaroch, S., Schmees, N., Rehwinkel, H., Hennekes, H., & Asadullah, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0300372101 · Cited by 466
Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434 · cited 1×
“Mice overexpressing 11β-HSD1, specifically in adipose tissue, develop visceral obesity, insulin resistance, dyslipidemia, and hypertension (9, 10).”
BackgroundPaterson, J. M., Morton, N. M., Fievet, C., Kenyon, C. J., Holmes, M. C., Staels, B., Seckl, J. R., & Mullins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305524101 · Cited by 431
Prevalence of oral glucocorticoid usage in the United States: a general population perspective
Overman, R. A., Yeh, J., & Deal, C. L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21796 · Cited by 405 · cited 3×
“E suggest that 1–2% of the population of the United States and United Kingdom take prescribed glucocorticoids (GCs) for the treatment of a broad spectrum of inflammatory and autoimmune diseases (1, 2).”
BackgroundMethodRosenstock, J., Banarer, S., Fonseca, V. A., Inzucchi, S. E., Sun, W., Yao, W., Hollis, G., Flores, R., Levy, R., Williams, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2315 · Cited by 316
Direct Effect of Glucocorticoids on Lipolysis in Adipocytes
Xu, C., He, J., Jiang, H., Zu, L., Zhai, W., Pu, S., & Xu, G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0464 · Cited by 291 · cited 1×
“In support, GCs are well known to directly stimulate lipolysis in adipose tissue, resulting in elevated serum free fatty acid levels (26).”
BackgroundCorticosteroid-induced clinical adverse events: frequency, risk factors and patient?s opinion
Fardet, L., Flahault, A., Kettaneh, A., Tiev, K. P., Généreau, T., Tolédano, C., Lebbé, C., & Cabane, J. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07950.x · Cited by 273
Karatsoreos, I. N., Bhagat, S. M., Bowles, N. P., Weil, Z. M., Pfaff, D. W., & McEwen, B. S. (2010) · Endocrinology · doi:10.1210/en.2009-1436 · Cited by 260
Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
Self-citationTomlinson, J. W., Sinha, B., Bujalska, I., Hewison, M., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020687 · Cited by 187
Self-citationMorgan, S. A., Sherlock, M., Gathercole, L. L., Lavery, G. G., Lenaghan, C., Bujalska, I. J., Laber, D., Yu, A., Convey, G., Mayers, R., et al. (2009) · Diabetes · doi:10.2337/db09-0525 · Cited by 167
Self-citationFeig, P. U., Shah, S., Hermanowski‐Vosatka, A., Plotkin, D., Springer, M. S., Donahue, S., Thach, C., Klein, E. J., Lai, E., & Kaufman, K. D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01375.x · Cited by 161
Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years
Hassan-Smith, Z. K., Sherlock, M., Reulen, R. C., Arlt, W., Ayuk, J., Toogood, A. A., Cooper, M. S., Johnson, A. P., & Stewart, P. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2957 · Cited by 153 · cited 2×
“J Clin Endocrinol Metab 97(6):2039–2049.”
BackgroundSelf-citationLin, C., Wu, T.-J., Machacek, D., Jiang, N., & Kao, P. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3687 · Cited by 138
11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects
Tiganescu, A., Tahrani, A. A., Morgan, S., Otranto, M., Desmoulière, A., Abrahams, L., Hassan-Smith, Z. K., Walker, E. A., Rabbitt, E. H., Cooper, M. S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64162 · Cited by 132
Self-citationFardet, L., Petersen, I., & Nazareth, I. (2012) · BMJ · doi:10.1136/bmj.e4928 · Cited by 130
Tiganescu, A., Walker, E. A., Hardy, R. S., Mayes, A. E., & Stewart, P. M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.257 · Cited by 122
Lin, C.-L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.151 · Cited by 98
Kinetics and Interconversion of Prednisolone and Prednisone Studied with New Radioimmunoassays
Meikle, A. W., WEED, J. A., & Tyler, F. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-4-717 · Cited by 87
Tomlinson, J., Draper, N., Mackie, J., Johnson, A. P., Holder, G., Wood, P. J., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8189 · Cited by 87
Self-citationLavery, G. G., Zielinska, A. E., Gathercole, L., Hughes, B. A., Semjonous, N. M., Guest, P., Saqib, K. M., Sherlock, M., Reynolds, G. M., Morgan, S., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1019 · Cited by 87
Self-citationBujalska, I. J., Walker, E. A., Tomlinson, J., Hewison, M., & Stewart, P. M. (2002) · Endocrine Research · doi:10.1081/erc-120016822 · Cited by 72
Self-citationZhang, J.-Z., Cavet, M. E., VanDerMeid, K. R., Salvador‐Silva, M., López, F. J., & Ward, K. W. (2009) · PubMed Central · Cited by 59
Semjonous, N. M., Sherlock, M., Jeyasuria, P., Parker, K. L., Walker, E. A., Stewart, P. M., & Lavery, G. G. (2010) · Endocrinology · doi:10.1210/en.2010-0957 · Cited by 58
Self-citationLin, C. W., Nakane, M., Stashko, M., Falls, D. H., Kuk, J. E., Miller, L. N., Huang, R., Tyree, C. M., Miner, J. N., Rosen, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.297 · Cited by 53
Cooper, M. S., Syddall, H. E., Fall, C. H. D., Wood, P. J., Stewart, P. M., Cooper, C., & Dennison, E. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02281.x · Cited by 48 · cited 1×
“Indeed, circulating cortisone levels have been shown to be negatively associated with bone mineral density and osteocalcin levels independent of circulating cortisol levels, suggesting 11βHSD1 activity within osteoblasts regulates bone mineral density (24).”
BackgroundHarno, E., Cottrell, E. C., Keevil, B. G., deSchoolmeester, J., Bohlooly‐Y, M., Andersén, H., Turnbull, A. V., Leighton, B., & White, A. E. (2013) · Endocrinology · doi:10.1210/en.2013-1362 · Cited by 45
5α‐Reduced glucocorticoids exhibit dissociated anti‐inflammatory and metabolic effects
Yang, C., Nixon, M., Kenyon, C. J., Livingstone, D., Duffin, R., Rossi, A., Walker, B., & Andrew, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01465.x · Cited by 34
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Inflammation and Skeletal Muscle Wasting During Cachexia
Webster, J. M., Kempen, L. J. A. P., Hardy, R. S., & Langen, R. C. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.597675 · Cited by 372
“This concept was lent further credit following a seminal study by Morgan et al. (2014) demonstrating that the systemic transgenic deletion of 11β-HSD1 in murine models of GC excess completely abrogated GC induced muscle wasting.”
BackgroundMorris, M. J., Beilharz, J. E., Maniam, J., Reichelt, A. C., & Westbrook, R. F. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.002 · Cited by 285
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Metadata
- Authors
- Morgan, S. A., McCabe, E. L., Gathercole, L. L., Hassan-Smith, Z. K., Larner, D. P., Bujalska, I. J., Stewart, P. M., Tomlinson, J. W., & Lavery, G. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-06-02
- Volume
- 111
- Issue
- 24
- Pages
- E2482-91
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2059237923
- Cited by
- 272
- References
- 33
- FWCI
- 20.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.